Favere K, Bosman M, Klingel K, Heymans S, Van Linthout S, Delputte P
Viruses. 2021; 13(6).
PMID: 34072044
PMC: 8227433.
DOI: 10.3390/v13061003.
Case L, Toussaint L, Moussawi M, Roberts B, Saligrama N, Brossay L
G3 (Bethesda). 2012; 2(1):115-21.
PMID: 22384388
PMC: 3276194.
DOI: 10.1534/g3.111.001610.
RABIN E, Hassan S, Jenson A, Melnick J
Am J Pathol. 1964; 44:775-97.
PMID: 14155025
PMC: 1907062.
Couvreur J
Arch Gesamte Virusforsch. 1963; 13:104-27.
PMID: 14023496
DOI: 10.1007/BF01243831.
Kearney M, Cotton J, Richardson P, Shah A
Postgrad Med J. 2000; 77(903):4-10.
PMID: 11123385
PMC: 1741887.
DOI: 10.1136/pmj.77.903.4.
Molecular typing of enteroviruses: current status and future requirements. The European Union Concerted Action on Virus Meningitis and Encephalitis.
Muir P, Kammerer U, Korn K, Mulders M, Poyry T, Weissbrich B
Clin Microbiol Rev. 1998; 11(1):202-27.
PMID: 9457433
PMC: 121380.
DOI: 10.1128/CMR.11.1.202.
The murine CAR homolog is a receptor for coxsackie B viruses and adenoviruses.
Bergelson J, Krithivas A, Celi L, Droguett G, Horwitz M, Wickham T
J Virol. 1998; 72(1):415-9.
PMID: 9420240
PMC: 109389.
DOI: 10.1128/JVI.72.1.415-419.1998.
Expression and distribution of the receptors for coxsackievirus B3 during fetal development of the Balb/c mouse and of their brain cells in culture.
Xu R, CROWELL R
Virus Res. 1996; 46(1-2):157-70.
PMID: 9029788
PMC: 7133877.
DOI: 10.1016/s0168-1702(96)01398-6.
Viral myocarditis. A review.
Woodruff J
Am J Pathol. 1980; 101(2):425-84.
PMID: 6254364
PMC: 1903609.
Residual pathologic changes following murine coxsackie A and B myocarditis.
Wilson F, Miranda Q, CHASON J, Lerner A
Am J Pathol. 1969; 55(2):253-65.
PMID: 5780700
PMC: 2013494.
[Studies on the offspring of mice infected with Coxsackie virus B 3].
Meyer J
Arch Gesamte Virusforsch. 1970; 30(4):316-26.
PMID: 5457236
Pathogenicity of the M and E variants of the encephalomyocarditis (EMC) virus. I. Myocardiotropic and neurotropic properties.
Craighead J
Am J Pathol. 1966; 48(2):333-45.
PMID: 4285783
PMC: 1916420.
Augmentation of the virulence of murine coxsackie-virus B-3 myocardiopathy by exercise.
Gatmaitan B, CHASON J, Lerner A
J Exp Med. 1970; 131(6):1121-36.
PMID: 4246139
PMC: 2138852.
DOI: 10.1084/jem.131.6.1121.
Clinical and experimental aspects of viral myocarditis.
Leslie K, Blay R, Haisch C, Lodge A, Weller A, Huber S
Clin Microbiol Rev. 1989; 2(2):191-203.
PMID: 2650861
PMC: 358110.
DOI: 10.1128/CMR.2.2.191.
Coxsackievirus infection as a trigger of cardiac autoimmunity.
Wolfgram L, Rose N
Immunol Res. 1989; 8(1):61-80.
PMID: 2647869
DOI: 10.1007/BF02918555.
